A new trading day began on Tuesday, with Adaptive Biotechnologies Corp (NASDAQ: ADPT) stock price remained unchanged from the previous day of trading, before settling in for the closing price of $11.74. ADPT’s price has ranged from $3.47 to $12.43 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -1.51% over the last five years. Meanwhile, its annual earnings per share averaged 21.47%. With a float of $144.91 million, this company’s outstanding shares have now reached $151.92 million.
The firm has a total of 619 workers. Let’s measure their productivity. In terms of profitability, gross margin is 61.06%, operating margin of -71.5%, and the pretax margin is -74.86%.
Adaptive Biotechnologies Corp (ADPT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Adaptive Biotechnologies Corp is 4.61%, while institutional ownership is 95.02%. The most recent insider transaction that took place on May 16 ’25, was worth 17,149. In this transaction Chief Financial Officer of this company sold 1,929 shares at a rate of $8.89, taking the stock ownership to the 277,396 shares. Before that another transaction happened on May 01 ’25, when Company’s Chief Scientific Officer sold 68,412 for $7.35, making the entire transaction worth $502,828. This insider now owns 1,279,524 shares in total.
Adaptive Biotechnologies Corp (ADPT) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 21.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.19% during the next five years compared to -1.51% drop over the previous five years of trading.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
Here are Adaptive Biotechnologies Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.64 in one year’s time.
Technical Analysis of Adaptive Biotechnologies Corp (ADPT)
Analysing the last 5-days average volume posted by the [Adaptive Biotechnologies Corp, ADPT], we can find that recorded value of 1.78 million was lower than the volume posted last year of 2.05 million. As of the previous 9 days, the stock’s Stochastic %D was 66.29%.
During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 88.83%, which indicates a significant increase from 70.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.60 in the past 14 days, which was lower than the 0.62 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.84, while its 200-day Moving Average is $7.38. Now, the first resistance to watch is $11.99. This is followed by the second major resistance level at $12.24. The third major resistance level sits at $12.51. If the price goes on to break the first support level at $11.48, it is likely to go to the next support level at $11.21. Should the price break the second support level, the third support level stands at $10.96.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Key Stats
With a market capitalization of 1.78 billion, the company has a total of 151,917K Shares Outstanding. Currently, annual sales are 178,960 K while annual income is -159,490 K. The company’s previous quarter sales were 52,440 K while its latest quarter income was -29,850 K.
